Men and older women have been shown to be at higher risk of adverse outcomes
Variables
Menopausal status
COCP (Combined Oral Contraceptive Pill)
HRT (Hormone Replacement Therapy)
152,637 women for menopause status
295,689 for COCP use
151,193 for HRT use
Results corrected for
Age
Smoking
BMI
Results
Post-menopausal women aged 40-60 years
More diagnosed cases
More symptoms
Trend (but not significant) to increased disease severity
Women aged 18-45 years taking COCP
Significantly lower prevalence of COVID-19 diagnosis
Reduction in hospital attendance (P = 0.023)
Post-menopausal women using HRT
Increased rates of COVID-19
No increase in hospitalization
